Epidemiology and antimicrobial resistance of Mycobacterium spp. in the United Arab Emirates: a retrospective analysis of 12 years of national antimicrobial resistance surveillance data
Frontiers in Public Health · 2024
DOI: 10.3389/fpubh.2024.1244353 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Public Health, 2024. Verfasst von Jens Thomsen und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Environmental and Occupational Health, Abu Dhabi Public Health Center, Abu Dhabi, United Arab Emirates. Hauptthemen laut MEDLINE: Tuberculosis, Multidrug-Resistant. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Introduction
The Eastern Mediterranean Regional Office (EMRO) region accounts for almost 8% of all global Mycobacterium tuberculosis (TB) cases, with TB incidence rates ranging from 1 per 100,000 per year in the United Arab Emirates (UAE) to 204 per 100,000 in Djibouti. The national surveillance data from the Middle East and North Africa (MENA) region on the epidemiology and antimicrobial resistance trends of TB, including MDR-TB remains scarce.
Methods
A retrospective 12-year analysis of N = 8,086 non-duplicate diagnostic Mycobacterium tuberculosis complex (MTB complex) isolates from the UAE was conducted. Data were generated through routine patient care during the 2010–2021 years, collected by trained personnel and reported by participating surveillance sites to the UAE National Antimicrobial Resistance (AMR) Surveillance program. Data analysis was conducted with WHONET, a windows-based microbiology laboratory database management software developed by the World Health Organization Collaborating Center for Surveillance of Antimicrobial Resistance, Boston, United States ( https://whonet.org/ ).
Results
A total of 8,086 MTB-complex isolates were analyzed. MTB-complex was primarily isolated from respiratory samples (sputum 80.1%, broncho-alveolar lavage 4.6%, pleural fluid 4.1%). Inpatients accounted for 63.2%, including 1.3% from ICU. Nationality was known for 84.3% of patients, including 3.8% Emiratis. Of UAE non-nationals, 80.5% were from 110 countries, most of which were Asian countries. India accounted for 20.8%, Pakistan 13.6%, Philippines 12.7%, and Bangladesh 7.8%. Rifampicin-resistant MTB-complex isolates (RR-TB) were found in 2.8% of the isolates, resistance to isoniazid, streptomycin, pyrazinamide, and ethambutol, was 8.9, 6.9, 3.4 and 0.4%, respectively. A slightly increasing trend of resistance among MTB-complex was observed for rifampicin from 2.5% (2010) to 2.8% (2021).
Conclusion
Infections due to MTB-complex are relatively uncommon in the United Arab Emirates compared to other countries in the MENA region. Most TB patients in the UAE are of Asian origin, mainly from countries with a high prevalence of TB. Resistance to first line anti-tuberculous drugs is generally low, however increasing trends for MDR-TB mainly rifampicin linked resistance is a major concern. MDR-TB was not associated with a higher mortality, admission to ICU, or increased length of hospitalization as compared to non-MDR-TB.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Environmental and Occupational Health, Abu Dhabi Public Health Center, Abu Dhabi, United Arab Emirates.
- Department of Pathology and Infectious Diseases, Khalifa University, Abu Dhabi, United Arab Emirates.
- Emirates Health Services Establishment, Dubai, United Arab Emirates.
- Department of Global Health, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South Africa.
- Rashid Hospital, Dubai, United Arab Emirates.
- Sheikh Khalifa Medical City, Abu Dhabi, United Arab Emirates.
Zitieren
APA
Thomsen, J., Abdulrazzaq, N. M., Nyasulu, P. S., Al Hosani, F., Habous, M., Weber, S., Jabeen, F., UAE AMR Surveillance Consortium, Menezes, G. A., Moubareck, C. A., Senok, A., & Everett, D. B. (2024). Epidemiology and antimicrobial resistance of Mycobacterium spp. in the United Arab Emirates: a retrospective analysis of 12 years of national antimicrobial resistance surveillance data. Frontiers in Public Health. https://doi.org/10.3389/fpubh.2024.1244353
Vancouver
Thomsen J, Abdulrazzaq NM, Nyasulu PS, Al Hosani F, Habous M, Weber S, et al. Epidemiology and antimicrobial resistance of Mycobacterium spp. in the United Arab Emirates: a retrospective analysis of 12 years of national antimicrobial resistance surveillance data. Frontiers in Public Health. 2024. doi:10.3389/fpubh.2024.1244353
BibTeX
@article{Thomsen2024,
author = {Thomsen, Jens and Abdulrazzaq, Najiba M and Nyasulu, Peter S and Al Hosani, Farida and Habous, Maya and Weber, Stefan and Jabeen, Fouzia and UAE AMR Surveillance Consortium, UAE AMR Surveillance Consortium and Menezes, Godfred Antony and Moubareck, Carole Ayoub and Senok, Abiola and Everett, Dean B},
title = {Epidemiology and antimicrobial resistance of Mycobacterium spp. in the United Arab Emirates: a retrospective analysis of 12 years of national antimicrobial resistance surveillance data},
journal = {Frontiers in Public Health},
year = {2024},
doi = {10.3389/fpubh.2024.1244353}
}
EUVIMED